Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
B Krishna Mohan / Hyderabad May 19, 2009, 0:38 IST With consumers switching to ever newer drugs, getting licences for changing product lines is an issue. The Bulk Drug Manufacturers Association (BDMA), which has over 500 members including 250 from Andhra Pradesh, has decided to request the Union government to …
The vaccine industry is waiting for a WHO decision on whether to keep making regular flu vaccine, or whether to switch to vaccines for the current swine flu outbreak.
President Obama engineered a political coup on Monday by bringing leaders of the health care industry to the White House to build momentum for his ambitious health care agenda. Mr. Obama pronounced it
Doctors, hospitals, drug makers and insurance companies will join President Obama on Monday in announcing their commitment to a sharp reduction in the growth of national health spending, White House officials said Sunday. The officials said the plan could save $2,500 a year for a family of four in the …
The Federation of Bangladesh Chambers of Commerce and Industry Thursday invited Nigeria to invest in various fields, especially in power sector, as the apex business body presented before a delegation from the African country huge investment opportunities here. They conveyed the invitation to the Nigerian government through the visiting Nigerian …
New Delhi: The government may have banned the distribution of Tamiflu and Relenza, two options available to battle the H1N1 influenza (or swine flu), but chemists say they are running out of stock despite selling Tamiflu at Rs 2,000 for 10 tablets. The enterprising chemist who arranged the drug for …
Researchers can continue most experiments on mankind's closest relatives -- chimpanzees, gorillas and orangutans -- after European Union lawmakers watered down proposals to restrict testing. The EU's executive Commission last year proposed a range of measures to improve the welfare of the 12 million vertebrate animals used in experiments each …
New Rules To Ensure 40-70% Cheaper Patented Medicines Reach Public System THE government is laying ground rules for negotiating drug prices with multinational companies to ensure that costly patented drugs are provided at 40-70% lower prices through the public health system, compared with those prevailing in the private health care …
Mumbai: The Indian clinical research industry has grown from Rs20crore to Rs1,500crore in the last three years. In India, the sector has not seen any near-term impact of the economic downturn as large pharma companies continue to send work to India, to be conducted at 1/5th of the US cost. …
May be the first new chemical entity developed and marketed by an Indian company. Malvinder singhSix years after the Geneva-based, not-for-profit organisation, Medicines for Malaria Venture (MMV), made Ranbaxy its drug development partner, the latter today announced the start of final-stage clinical trials for a new anti-malaria drug. Ranbaxy expects …
Warning of significant takeover threats for most Indian drugmakers by their large foreign peers, an inter-ministerial task force has suggested the Government act proactively to strengthen the pharma industry. "(The) Indian pharmaceutical industry being fragmented with small balance sheet sizes, takeover by global pharmaceutical companies would adversely affect the health …
New Delhi, May 4 Ranbaxy Laboratories Ltd on Monday announced the commencement of the third phase clinical trials for its new anti-malaria combination drug in India, Bangladesh and Thailand. The drug, Arterolane maleate + Piperaquine phosphate, is targeted at patients in developing countries with the aim of significantly improving upon …
LARGE PARTS OF MEXICO REMAIN SHUT AS TRAVEL SUFFERS AS a new flu strain spreads around the world, many of the largest US companies have halted business travel to Mexico and are increasing efforts to keep workplaces free of germs, but measures remain low-key. Companies are dusting off contingency plans …
PB Jayakumar / Mumbai May 2, 2009, 0:14 IST Tokyo's policy push for generics an added draw. Leading Indian drug makers such as Ranbaxy, Lupin, Zydus Cadila and Dishman, which forayed into Japan in the past three years, have emerged as important players in the generic or copycat drug business …
Pharma companies would be well advised, as part of their corporate social responsibility, to recruit audit bodies to protect their reputation and investment and ensure that clinical trials are safely conducted, says Olinda Timms INDIA has emerged as one of the preferred destinations for the clinical trials of drugs by …
Govt Decision To Stock 10 M Doses Means Rs 250-Cr Biz For Pharma Cos THE ministry of health & family welfare will stockpile 10 million doses of anti-viral drug oseltamavir in the next seven days as a precautionary measure against a possible outbreak of swine flu, which has been officially …
India plans to increase stockpiles of the anti-influenza drug Tamiflu or its generic version by 10-fold, from one million to 10 million currently, Bloomberg reported, citing Vineet Choudhary, joint secretary, Ministry of Health. India has also received quotations for supply of the drug from Ranbaxy Laboratories, Cipla, Hetero Drugs and …
Federal officials said it would take until January, or late November at the earliest, to make enough vaccine to protect all Americans from a possible epidemic of swine flu. And beyond the US and a few other countries that also make vaccines, some experts said it could take years to …
